Nivolumab,Ipilimumab,Cisplatin,Vinorelbine,Gemcitabine,Docetaxel,Pemetrexed,Carboplatin,Paclitaxel,Toripalimab
bms,Coherus,Junshi Biosciences,merck
['lung']
more evidence of benefit of neo-adjuvant chemo-immunotherapy uk needs to adapt pathways to ensure all suitable patients benefit in order to improve outcomes in early stage lung cancer. #asco2023 
Thoracic Medical Oncologist @BartsHospital, PhD in genomic medicine @Imperialcollege, Representative @ACPUK & @BTOGorg, @FMLM_UK clinical Fellow ‘18